Literature DB >> 18173552

Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer.

B M Erovic1, M Woegerbauer, J Pammer, E Selzer, M Ch Grasl, D Thurnher.   

Abstract

BACKGROUND: Cyclooxygenase-1, in contrast to cyclooxygenase-2, is generally reported to be constitutively expressed as a housekeeping enzyme in many different tissues. A number of recently published reports, however, challenge the notion that cyclooxygenase-1 expression is invariably constitutive by demonstrating that this enzyme might be up-regulated under certain pathological conditions in, for example, breast or ovarian cancer cells. In this study we investigated the expression of cyclooxygenase-1 in head and neck tumours and compared it to the cyclooxygenase-1 expression levels in normal oropharyngeal epithelial cells.
MATERIAL AND METHODS: Paraffin-embedded pretreatment biopsies were obtained from head and neck tumour patients (n = 35). In addition, samples of normal oropharyngeal mucosa were taken from patients (n = 12) undergoing routine tonsillectomy. Cyclooxygenase-1 expression levels were determined by immunohistochemistry, Western blotting and real-time RT-PCR in cancerous tissue versus normal mucosa.
RESULTS: Immunohistochemistry revealed overexpression of cyclooxygenase-1 in tumour biopsies compared to normal mucosa. Cyclooxygenase-1 was highly synthesized in the cytoplasm of neoplastic cells while significantly lower levels were detectable in normal mucosal cells. Western blotting and real-time RT-PCR also demonstrated higher cyclooxygenase-1 levels in tumour specimens compared to normal tissue samples.
CONCLUSION: In this study we show for the first time that cyclooxygenase-1 is overexpressed in head and neck cancer cells compared to epithelial cells of normal mucosa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18173552     DOI: 10.1111/j.1365-2362.2007.01896.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors.

Authors:  Md Jashim Uddin; Anna V Elleman; Kebreab Ghebreselasie; Cristina K Daniel; Brenda C Crews; Kellie D Nance; Tamanna Huda; Lawrence J Marnett
Journal:  ACS Med Chem Lett       Date:  2014-10-12       Impact factor: 4.345

2.  New diagnostic markers in salivary gland tumors.

Authors:  Sven Schneider; Philipp Kloimstein; Johannes Pammer; Werner Brannath; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-04       Impact factor: 2.503

3.  Effects of cyclooxygenase inhibitors on survival time in ovarian cancer xenograft-bearing mice.

Authors:  Wei Li; Xiao-Li Xu; Jun Zhang; Jia-Hui Cai; Yun-Xian Tang
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

4.  PET radiotracer [¹⁸F]-P6 selectively targeting COX-1 as a novel biomarker in ovarian cancer: preliminary investigation.

Authors:  Maria Grazia Perrone; Paola Malerba; Jashim Uddin; Paola Vitale; Andrea Panella; Brenda C Crews; Cristina K Daniel; Kebreab Ghebreselasie; Mike Nickels; Mohammed N Tantawy; H Charles Manning; Lawrence J Marnett; Antonio Scilimati
Journal:  Eur J Med Chem       Date:  2014-04-29       Impact factor: 6.514

5.  Minor salivary gland carcinoma: a review of 35 cases.

Authors:  Georg Haymerle; Sven Schneider; Luke Harris; Theresia Häupl; Christian Schopper; Johannes Pammer; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-23       Impact factor: 2.503

6.  Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.

Authors:  Wei Li; Liang Wan; Ling-Yun Zhai; Jane Wang
Journal:  Int J Mol Sci       Date:  2014-10-23       Impact factor: 5.923

7.  Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts.

Authors:  Alicia González-González; Enrique García Nieto; Alicia González; Cristina Sánchez-Fernández; Carolina Alonso-González; Javier Menéndez-Menéndez; José Gómez-Arozamena; Samuel Cos; Carlos Martínez-Campa
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

8.  Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.

Authors:  C Martínez-Campa; A González; M D Mediavilla; C Alonso-González; V Alvarez-García; E J Sánchez-Barceló; S Cos
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

9.  Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.

Authors:  G O'Callaghan; J Kelly; F Shanahan; A Houston
Journal:  Br J Cancer       Date:  2008-07-22       Impact factor: 7.640

10.  Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas.

Authors:  Nasrin Akbari; Mohammad Ghorbani; Vahid Salimi; Alimohammad Alimohammadi; Mohammad E Khamseh; Hamideh Akbari; Mitra Nourbakhsh; Alireza Sheikhi; S Fahimeh Taghavi; Masoumeh Tavakoli-Yaraki
Journal:  BMC Endocr Disord       Date:  2020-03-14       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.